MedTrace Logo

To Collect Enriched Human Serum Following Hydrolyzed Collagen Intake

NCT07195396 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 3

Last updated 2026-01-20

No results posted yet for this study

Summary

This randomized, double-blind, monocentric, five-way cross-over study aims to collect human serum and plasma samples at 1 and 2 hours after ingestion of hydrolyzed collagen peptides. The enriched sera will be used for ex vivo/ in vitro experiments on skin keratinocytes, fibroblasts, and other cell types to explore the beneficial effects of bioactive collagen peptides. Blood will also be analyzed for amino acid profiles and collagen-derived peptides.

Conditions

  • Healthy Women

Interventions

DIETARY_SUPPLEMENT

Collagen hydrolysate 1

10g single oral dose dissolved in water

DIETARY_SUPPLEMENT

Collagen hydrolysate 2

10g single oral dose dissolved in water

DIETARY_SUPPLEMENT

Collagen hydrolysate 3

10g single oral dose dissolved in water

DIETARY_SUPPLEMENT

Collagen hydrolysate 4

10g single oral dose dissolved in water

DIETARY_SUPPLEMENT

Collagen hydrolysate 5

10g single oral dose dissolved in water

Sponsors & Collaborators

  • BioTeSys GmbH

    collaborator OTHER

  • Rousselot BVBA

    lead INDUSTRY

Principal Investigators

  • Praneeth Reddy Kuninty, PhD · Rousselot BV

Study Design

Allocation
RANDOMIZED
Purpose
BASIC_SCIENCE
Masking
TRIPLE
Model
CROSSOVER

Eligibility

Min Age
35 Years
Max Age
45 Years
Sex
FEMALE
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2025-10-22
Primary Completion
2025-12-22
Completion
2025-12-22

Countries

  • Germany

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT07195396 on ClinicalTrials.gov